Michael York - 18 Feb 2022 Form 3 Insider Report for Metacrine, Inc.

Role
Chief Business Officer
Signature
/s/ Michael York
Issuer symbol
N/A
Transactions as of
18 Feb 2022
Net transactions value
$0
Form type
3
Filing time
24 Feb 2022, 15:52:00 UTC
Previous filing
24 May 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MTCR Stock Option (right to buy) 18 Feb 2022 Common Stock 235,000 $1.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest one year after the Vesting Commencement Date of December 1, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter until fully vested on December 1, 2025.